Abstract
Background: Coronavirus disease 19 (COVID-19) carries a high mortality rate among older patients and minorities such as ethnic Africans and Latinos. These patients suffer from chronic inflammation that may turn into a cytokine storm when infection occurs, in addition to frequently possessing multiple comorbidity factors that may also account for their higher mortality. Even though multiple organ failure results from the cytokine storm, it is pneumonia and respiratory failure that often lead to death. Low-dose-whole-lung radiotherapy (LDWLRT) may modulate the inflammatory response and decrease the need for artificial ventilation, thus improving the mortality rate.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
